The dopamine β-hydroxylase-1021C/T polymorphism is associated with the risk of Alzheimer's disease in the Epistasis Project
Onofre Combarros, Donald R Warden, Naomi Hammond, Mario Cortina-Borja, Olivia Belbin, Michael G Lehmann, Gordon K Wilcock, Kristelle Brown, Patrick G Kehoe, Rachel Barber, Eliecer Coto, Victoria Alvarez, Panos Deloukas, Rhian Gwilliam, Reinhard Heun, Heike Kölsch, Ignacio Mateo, Abderrahim Oulhaj, Alejandro Arias-Vásquez, Maaike Schuur, Yurii S Aulchenko, M Arfan Ikram, Monique M Breteler, Cornelia M van Duijn, Kevin Morgan, A David Smith, Donald J Lehmann
2010-12-01
Abstract:Background The loss of noradrenergic neurones of the locus coeruleus is a major feature of Alzheimer's disease (AD). Dopamine β-hydroxylase (DBH) catalyses the conversion of dopamine to noradrenaline. Interactions have been reported between the low-activity -1021T allele (rs1611115) of DBH and polymorphisms of the pro-inflammatory cytokine genes, IL1A and IL6, contributing to the risk of AD. We therefore examined the associations with AD of the DBH -1021T allele and of the above interactions in the Epistasis Project, with 1757 cases of AD and 6294 elderly controls. Methods We genotyped eight single nucleotide polymorphisms (SNPs) in the three genes, DBH, IL1A and IL6. We used logistic regression models and synergy factor analysis to examine potential interactions and associations with AD. Results We …